Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Academab Biomedical Inc.

Clinical trials sponsored by Academab Biomedical Inc., explained in plain language.

Trials to join now! 1

New antibody infusion AM-928 enters early human trials for Hard-to-Treat cancers

Disease control Recruiting now

This early-phase study tests a new drug called AM-928, given as an IV infusion, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can help control tumor growth…

Phase: PHASE1 • Sponsor: AcadeMab Biomedical Inc. • Aim: Disease control

Last updated May 26, 2026 06:06 UTC